Resonance Health: Half Year Report & Accounts

There were no dividends paid, recommended or declared during the current financial period. Comments The profit for the Group after providing for income tax amounted to $1,466,049 (31 December 2024: $1,036,192 loss). The FY26 half year result included an income tax benefit of $561,343 which was the net difference between the Group’s Research and Development (R&D) tax incentive refund for R&D perfor